Market revenue in 2023 | USD 377.8 million |
Market revenue in 2030 | USD 620.0 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Bench top |
Fastest growing segment | Bench Top |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bench Top |
Key market players worldwide | Danaher Corp, Roche Holding AG ADR, Fortress Diagnostics, Life Healthcare Group Holdings Ltd, Nova Biomedical, Optimi Health Corp, Sensas, Siemens Healthineers AG ADR, Abbott Laboratories, Meizhou Cornley Hi-Tech Co., Edan Instruments, ERBA Diagnostics Mannheim, Werfen, Medicia Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood gas & electrolyte analyzer market will help companies and investors design strategic landscapes.
Bench top was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific blood gas & electrolyte analyzer market based on bench top covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific blood gas & electrolyte analyzer market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific blood gas & electrolyte analyzer market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account